Publication | Closed Access

Effectiveness and safety of apixaban therapy in daily-care patients with atrial fibrillation: results from the Dresden NOAC Registry

ThrombosisCardiovascular DiseaseDresden Noac RegistryMedicinePatient SafetyCardiovascular PharmacologyPharmacotherapyCoagulopathyAtrial FibrillationPublic HealthPlatelet AntagonistApixaban TherapyAnticoagulantCardiologyAnesthesiology